Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion

ClinicalTrials.gov ID: NCT03248440

Public ClinicalTrials.gov record NCT03248440. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion (SUN-131-03)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This protocol for SUN-131 1.5% TDS is developed for the treatment of chalazion. SUN-131 1.5% TDS is designed for local delivery of a corticosteroid, to the upper or lower eyelid. The purpose of this study is to evaluate the efficacy and safety of SUN-131 1.5% TDS as compared with placebo TDS in the treatment of a chalazion.

Study identification

NCT ID
NCT03248440
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Senju USA, Inc.
Industry
Enrollment
263 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2017 (Actual)
Primary completion
Aug 17, 2018 (Actual)
Completion
Aug 17, 2018 (Actual)
Last update posted
Aug 5, 2021

2017 – 2018

United States locations

U.S. sites
65
U.S. states
23
U.S. cities
59
Facility City State ZIP Site status
SUN-131-03 Investigational Site Chandler Arizona 85225 —
SUN-131-03 Investigational Site Prescott Arizona 86301 —
SUN-131-03 Investigational Site Sun City Arizona 85351 —
SUN-131-03 Investigational Site Glendale California 91204 —
SUN-131-03 Investigational Site Lancaster California 93534 —
SUN-131-03 Investigational Site Long Beach California 90805 —
SUN-131-03 Investigational Site Los Angeles California 90048 —
SUN-131-03 Investigational Site Mission Hills California 91345 —
SUN-131-03 Investigational Site Petaluma California 94954 —
SUN-131-03 Investigational Site Rancho Cordova California 95670 —
SUN-131-03 Investigational Site San Diego California 92115 —
SUN-131-03 Investigational Site Santa Ana California 92705 —
SUN-131-03 Investigational Site Colorado Springs Colorado 80907 —
SUN-131-03 Investigational Site Littleton Colorado 80120 —
SUN-131-03 Investigational Site Fort Myers Florida 33901 —
SUN-131-03 Investigational Site Largo Florida 33773 —
SUN-131-03 Investigational Site Maitland Florida 32751 —
SUN-131-03 Investigational Site Tamarac Florida 33321 —
SUN-131-03 Investigational Site Albany Georgia 31701 —
SUN-131-03 Investigational Site Morrow Georgia 30260 —
SUN-131-03 Investigational Site Roswell Georgia 30076 —
SUN-131-03 Investigational Site Chicago Ridge Illinois 60415 —
SUN-131-03 Investigational Site Glenview Illinois 60026 —
SUN-131-03 Investigational Site Hoffman Estates Illinois 60169 —
SUN-131-03 Investigational Site Lake Villa Illinois 60046 —
SUN-131-03 Investigational Site Leawood Kansas 66211 —
SUN-131-03 Investigational Site Shawnee Mission Kansas 66204 —
SUN-131-03 Investigational Site Lexington Kentucky 40509 —
SUN-131-03 Investigational Site Louisville Kentucky 40206 —
SUN-131-03 Investigational Site Saint Joseph Michigan 49085 —
SUN-131-03 Investigational Site Bloomington Minnesota 55420 —
SUN-131-03 Investigational Site Kansas City Missouri 64133 —
SUN-131-03 Investigational Site St Louis Missouri 63131 —
SUN-131-03 Investigational Site Washington Missouri 63090 —
SUN-131-03 Investigational Site Las Vegas Nevada 89119 —
SUN-131-03 Investigational Site Las Vegas Nevada 89123 —
SUN-131-03 Investigational Site Wantagh New York 11793 —
SUN-131-03 Investigational Site Asheville North Carolina 28803 —
SUN-131-03 Investigational Site Charlotte North Carolina 28210 —
SUN-131-03 Investigational Site High Point North Carolina 27262 —
SUN-131-03 Investigational Site Cincinnati Ohio 45236 —
SUN-131-03 Investigational Site Cincinnati Ohio 45247 —
SUN-131-03 Investigational Site Mason Ohio 45040 —
SUN-131-03 Investigational Site Lancaster Pennsylvania 17601 —
SUN-131-03 Investigational Site Lancaster Pennsylvania 19087 —
SUN-131-03 Investigational Site Philadelphia Pennsylvania 19148 —
SUN-131-03 Investigational Site Wayne Pennsylvania 19087 —
SUN-131-03 Investigational Site Florence South Carolina 29501 —
SUN-131-03 Investigational Site Rapid City South Dakota 57701 —
SUN-131-03 Investigational Site Chattanooga Tennessee 37411 —
SUN-131-03 Investigational Site Memphis Tennessee 38119 —
SUN-131-03 Investigational Site Nashville Tennessee 37215 —
SUN-131-03 Investigational Site Cedar Park Texas 78613 —
SUN-131-03 Investigational Site Houston Texas 77008 —
SUN-131-03 Investigational Site Houston Texas 77034 —
SUN-131-03 Investigational Site Houston Texas 77055 —
SUN-131-03 Investigational Site Lakeway Texas 78734 —
SUN-131-03 Investigational Site Mission Texas 78572 —
SUN-131-03 Investigational Site San Antonio Texas 78209 —
SUN-131-03 Investigational Site San Antonio Texas 78240 —
SUN-131-03 Investigational Site Salt Lake City Utah 84117 —
SUN-131-03 Investigational Site Exmore Virginia 23350 —
SUN-131-03 Investigational Site Falls Church Virginia 22046 —
SUN-131-03 Investigational Site Norfolk Virginia 23456 —
SUN-131-03 Investigational Site Racine Wisconsin 53405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03248440, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03248440 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →